Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HFNC Versus NIV in Hypercapneic COPD Patients

NCT: NCT07854210 · RECRUITING

NCT IDNCT07854210
StatusRECRUITING
Start Date2025-11-03
Completion2026-12
SponsorMohammed Shehta (OTHER)
First posted
Last updated

Brief Summary

Aim: To compare gas exchange trends, clinical outcomes, and tolerability between HFNC and NIV in COPD patients with mild-to-moderate hypercapnic respiratory failure.

Frequently Asked Questions

What is HFNC Versus NIV in Hypercapneic COPD Patients?

HFNC Versus NIV in Hypercapneic COPD Patients is a clinical trial registered under NCT07854210. Current status: RECRUITING.

What is the status of NCT07854210?

The current status of NCT07854210 (HFNC Versus NIV in Hypercapneic COPD Patients) is: RECRUITING.

When did HFNC Versus NIV in Hypercapneic COPD Patients start?

HFNC Versus NIV in Hypercapneic COPD Patients started on 2025-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑